Head and Neck Cancer: Multimodality Management

ISBN-13: 9783319275994 / Angielski / Twarda / 2016 / 878 str.

Jacques Bernier

Opis

​This second edition ​provides a comprehensive view of consolidated and innovative concepts, in terms of both diagnosis and treatment. Written by leading international physicians and investigators, this book emphasizes the necessity of combining local and systemic treatments to achieve the objective of yielding higher cure rates and lower toxicities. Heavily updated from the previous edition, it highlights new surgery and radiotherapy techniques, disease awareness, patient quality of life, and comprehensive management.
Head-and-neck cancers are a complex clinical entity and their response to treatment is also known to vary markedly in function of host-related factors. Notwithstanding the impressive progresses observed in the field of imaging, head and neck cancers are often diagnosed at a late stage and the presence of locally advanced disease in a significant number of patients implies the use of aggressive treatments in order to both ensure local disease control and reduce distant metastasis risks.
In comparison with the first edition, Head and Neck Cancer, Second Edition provides a detailed update of innovative concepts in chemo- and bio-radiation, viral infection impact on tumor growth and response to treatment, and impact of tumor- and host-related factors on treatment outcome.

Recenzje

"This exceptional, up-to-date resource on the basic and clinical science of head and neck cancer synthesizes a vast amount of information in a single, comprehensive resource. ... Specialists ... as well as trainees in these fields, will find this an outstanding resource. ... an extraordinary guide to this field. Those looking for a comprehensive resource on head and neck cancer will not find a better one. ... it will soon become the definitive book on head and neck cancer." (John David Cramer, Doody's Book Reviews, January, 2017)

Spis treści

Table of Contents

Head and Neck Cancer: Multimodality Management, 2nd Edition

Editors: Jacques Bernier

Ch. 1: Epidemiology and Aetiology of Head and Neck Cancers

Newell W. Johnson

Hemantha K. Amarasinghe

Ch. 2: Head and Neck Cancer Prevention

Fausto Chiesa

Angelo Ostuni

Roberto Grigolato

Luca Calabrese

Mohssen Ansarin

Ch. 3: Cellular and Molecular Pathology of Head and Neck Tumors

Adel K. El-Naggar

Ch. 4: Oncogenomics/Proteomics of Head and Neck Cancers

Jason I. Kass

Howard S. Moskowitz

Jennifer R. Grandis

Ch. 5: Genetics and Epigenetics of Head and Neck Cancer

Jagtar Dhanda

Richard J. Shaw

Ch. 6: Immunology of Head and Neck Cancer

Benjamin A. Kansy

Steve C. Lee

Robert L. Ferris

Ch. 7: Biomarkers in Head and Neck Cancer

Hyunseok Kang

Christine H. Chung

Arlene A. Forastiere

Ch. 8: HPV and EBV in Head and Neck Cancer

Jeffrey Brumbaugh

Robert L. Ferris

Shen Hu

Ch. 9: Head and Neck Cancer Staging and Prognosis: Perspectives of the UICC and the AJCC

Brian O’Sullivan

Jatin P. Shah

William M. Lydiatt

Ch. 10: Preclinical Models of Head and Neck Squamous Cell Carcinoma

C.L. Zuur

A.J.C. Dohmen

Michiel W. van den Brekel

Xiao-Jing Wang

Stephen Malkoski

Ch. 11: Translational Research in Head and Neck Oncology

David S. Yoo

David M. Brizel

Ch. 12: Hypoxia in Head and Neck Cancers: Clinical Relevance and Treatment

Yungan Tao

Jean Bourhis

Ch. 13: Imaging of Head and Neck Cancers

Taha S. Meraj

Suyash Mohan

Gaurang V. Shah

Ch. 14: Ultrasound Investigations in Head & Neck Cancer Patients

Yolanda Y.P. Lee

Ka Tak Wong

Kunwar Suryaveer Singh Bhatia

Anil Tejbhan Ahuja

Ch. 15: Sentinel Node Biopsy

Oliver J. Smith

Lee W.T. Alkureishi

Gary L. Ross

Ch. 16: Intensity-Modulated Radiation Therapy for Head and Neck Cancer

Marsha Reyngold

Edward J. Shin

Nancy Lee

Ch. 17: Stereotactic Radiotherapy in Head and Neck Cancer Patients

Thomas Leroy

Eric Lartigau

Ch. 18: Proton Beam Therapy for Head and Neck Cancer

Danielle N. Margalit

Judy A. Adams

Hanne M. Kooy

Annie W. Chan

<

Ch. 19: Principles of Systemic Chemotherapy for Squamous Cell Head and Neck Cancer

Cristina P. Rodriguez

David J. Adelstein

Ch. 20: Molecular Targeted Therapies in Head and Neck Cancer

Zachary S. Morris

Anne M. Traynor

Paul M. Harari

Ch. 21: Laser Endoscopic Treatment

Pierre Moreau

Pierre Demez

Ch. 22: Transoral robotic surgery in head and neck cancer

Sylvain Morinière 

Ch. 23: Multidisciplinary Management of Skull Base and Superstructure Tumors

Giulio Cantù

Carlo L. Solero

Stefano Riccio

Sarah Colombo

Madia Pompilio

Ch. 24: Multidisciplinary management of oral cavity and maxillary sinus cancers

Alexander D. Rapidis

Ch. 25: Oral Oncology

Ruth Aponte Wesson

Theresa M. Hofstede

Richard C. Cardoso

Pattii Montgomery

Alexander M. Won

Jack W. Martin

Mark S. Chambers

Ch. 26: Management of Nasopharyngeal Carcinoma

Wai Tong Ng

Roger K.C. Ngan

Siu Hong Chan

Henry Sze

Jimmy Y.W. Chan

Anne W.M. Lee

Ch. 27: Multidisciplinary management of oropharynx carcinomas

Beth M. Beadle

David I. Rosenthal

Ch. 28: Multidisciplinary Management of Hypopharyngeal Carcinoma

Marc Hamoir

Jean-Pascal Machiels

Sandra Schmitz

Vincent Gregoire

Ch. 29: Cancers of the Larynx: Tis, T1, T2 Evaluation and Management

Carol M. Lewis

Steven B. Chinn

Chris Holsinger

Randal S. Weber

Ch. 30: Diagnosis and Multidisciplinary Treatment of Laryngeal Cancers

Nabil F. Saba

J. Trad Wadsworth

Jonathan J. Beitler

Fadlo R. Khuri

Ch. 31: Programs of Organ and Function Preservation

Jean Louis Lefebvre

Ch. 32: Principles and New Approaches in Surgical Reconstruction

Andreas Dietz

Milos Fischer

Christina Magill

Bruce H. Haughey

Ch. 33: Multidisciplinary treatment of the neck

Remco de Bree

Johannes A. Langendijk

C.R. Leemans

Ch. 34: Postoperative Management of High-Risk Resectable Head and Neck Cancer

Assuntina G. Sacco

Ezra E. Cohen

Ch. 35: Multidisciplinary Approach of Unresectable Head and Neck Cancer

Ricardo Hitt

Ana Lopez-Martin

Juan J. Cruz

Robert I. Haddad

Ch. 36: Management of Salivary Gland Cancer

Laura D. Locati

Marco Guzzo

Ester Orlandi

Lisa Licitra

Ch. 37: Primary Mucosal Melanomas of the Head and Neck

Juliette Thariat

Anne-Catherine Baglin

Pierre Yves Marcy

Caroline Even

Antoine Moya-Plana

Yusuke Demizu

Adam S. Garden

Marco Krengli

Michael A. Postow

Ch. 38: Head & Neck Cutaneous Melanoma

Mina N. Le

Michael A. Postow

Snehal G. Patel

Ch. 39: Cervical Lymph Node Metastases Of Squamous Cell Carcinoma From An Unknown Primary Site

Nicholas Pavlidis

Georgios Plataniotis

Ch. 40: The Management of Thyroid and Parathyroid Cancer

Nasheed M. Hossain

Colleen Veloski

Ranee Mehra

Ch. 41: Head and Neck Paragangliomas

Julian Künzel

Michael Hainz

Heidi Rossmann

Christoph Matthias

Ch. 42: Systemic Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Petr Szturz

Jan B. Vermorken

Ch. 43: Phase I study methodology in head and neck oncology

Aaron Hansen

Christophe Le Tourneau

Ch. 44: Treatment of the Elderly Head and Neck Cancer Patient

Jean-Claude Horiot

Matti Aapro

Ch. 45: Normal Tissue Complications and Protection in Head and Neck Cancer Patients

Andy Trotti

Nikhil Rao

Avraham Eisbruch

David I. Rosenthal

Ch. 46: Advances in Management of Complications for Head and Neck Cancer Therapy

Barbara Murphy

Jie Deng

Mark J. Stavas

Heidi Ganzer

Joel B. Epstein

Ch. 47: Rehabilitation of Heavily Treated Head and Neck Cancer Patients

Katherine A. Hutcheson

Ch. 48: Salvage Therapy in Head and Neck Cancer Patients

John Heaphy

Rod Rezaee

Pierre Lavertu

Ch. 49: Quality of Life in Head and Neck Cancer Patients

Jolie Ringash

Ch. 50: Psycho-oncologic aspects of head and neck cancer patients

Michel Reich

Ch. 51: Advances in Nanomedicine for Head and Neck Cancer

Sajanlal R. Panikkanvalappil

Mostafa A. El-Sayed

Ivan H. El-Sayed

Ch. 52: Head and Neck Quality Assurance 2014

Thomas J. FitzGerald

Maryann Bishop-Jodoin

David S. Followill

James M. Galvin

Michael V. Knopp

Jeff M. Michalski

Mark Rosen

Jonathan M. Glanzman

Paul Rava

Allison Sacher

David J. Goff

Alec Vaezi

Kenneth Ulin

O autorze

After obtaining his degree in Radio-Oncology at the University of Liege, Belgium, Jacques Bernier completed his training at the MD Anderson Cancer Center, Houston, and the Curie Institute, Paris. In 2006 he joined the Swiss Genolier Medical Network, where since then he has been chairing the Radio-Oncology Department. Throughout most of his career, Jacques Bernier has been heavily involved with translational and clinical research. From 2000 to 2006 Jacques Bernier was Chairman of the Head and Neck Group of the EORTC. He currently serves as an Editorial Board member of various international peer-reviewed journals, including “Journal of Clinical Oncology”. He is an Associate Editor of “Annals of Oncology” (since 2010), and “Oral Oncology” (since January 2011). A Course Director at the European School of Oncology since 1990, Jacques Bernier is also the Chairman of the International Conference on Translational Research in Radio-Oncology - ICTR, organized every three years in Switzerland. He serves as a regular member of advisory boards for many pharmaceutical companies. He is President of the Foundation for the Advancement of Radiation Oncology – FARO, in Geneva, member of the Executive Board of Euro-Asian Society of Mastology - EURAMA, Board of Trustees of “Science for Peace” and Scientific Committee of the “Umberto Veronesi Foundation” in Milan.